Your browser doesn't support javascript.
loading
Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures.
Padhan, Kartika; Moysi, Eirini; Noto, Alessandra; Chassiakos, Alexander; Ghneim, Khader; Perra, Maria Maddalena; Shah, Sanjana; Papaioannou, Vasilis; Fabozzi, Giulia; Ambrozak, David R; Poultsidi, Antigoni; Ioannou, Maria; Fenwick, Craig; Darko, Samuel; Douek, Daniel C; Sekaly, Rafick-Pierre; Pantaleo, Giuseppe; Koup, Richard A; Petrovas, Constantinos.
Affiliation
  • Padhan K; Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Moysi E; Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Noto A; Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
  • Chassiakos A; Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Ghneim K; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106.
  • Perra MM; Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
  • Shah S; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Papaioannou V; Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Fabozzi G; Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Ambrozak DR; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Poultsidi A; Medical School, University of Thessaly, Larissa 41222, Greece.
  • Ioannou M; Medical School, University of Thessaly, Larissa 41222, Greece.
  • Fenwick C; Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
  • Darko S; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Douek DC; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Sekaly RP; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106.
  • Pantaleo G; Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
  • Koup RA; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814.
  • Petrovas C; Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814; petrovasc@mail.nih.gov.
Proc Natl Acad Sci U S A ; 118(18)2021 05 04.
Article in En | MEDLINE | ID: mdl-33903232
ABSTRACT
The development of follicular helper CD4 T (TFH) cells is a dynamic process resulting in a heterogenous pool of TFH subsets. However, the cellular and molecular determinants of this heterogeneity and the possible mechanistic links between them is not clear. We found that human TFH differentiation is associated with significant changes in phenotypic, chemokine, functional, metabolic and transcriptional profile. Furthermore, this differentiation was associated with distinct positioning to follicular proliferating B cells. Single-cell T cell receptor (TCR) clonotype analysis indicated the transitioning toward PD-1hiCD57hi phenotype. Furthermore, the differentiation of TFH cells was associated with significant reduction in TCR level and drastic changes in immunological synapse formation. TFH synapse lacks a tight cSMAC (central supra molecular activation Cluster) but displays the TCR in peripheral microclusters, which are potentially advantageous in the ability of germinal center (GC) B cells to receive necessary help. Our data reveal significant aspects of human TFH heterogeneity and suggest that the PD-1hiCD57hi TFH cells, in particular, are endowed with distinctive programming and spatial positioning for optimal GC B cell help.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / Cell Differentiation / Cell Lineage / T Follicular Helper Cells Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / Cell Differentiation / Cell Lineage / T Follicular Helper Cells Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2021 Document type: Article